Dr. Coombs on Exciting CLL Therapies at SOHO 2024

By Catherine Coombs, MD - Last Updated: September 25, 2024

Callie Coombs, MD, of the University of California, Irvine, discusses what she is most looking forward to in chronic lymphocytic leukemia (CLL) at the Society of Hematologic Oncology 2024 Annual Meeting.

Advertisement

Specifically, Dr. Coombs discussed time limited therapies and the phase III AMPLIFY trial, which evaluated acalabrutinib plus venetoclax in patients with CLL.

Post Tags:SOHO 2024
Advertisement
Advertisement
Advertisement
Editorial Board